Internal Medicine, Hematology & Oncology · Indianapolis, IN
NPI
1962848507
Since 2013
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
8326 Naab Rd
Indianapolis, IN, 46260
Phone (317) 871-0000
Groups this clinician bills Medicare through
Medicare paid, 2024
$14K
208 services
Medicare patients, 2024
115
Average age 69
Drug cost, 2024
$245K
497 prescriptions
Company payments, 2025
$1,276
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrew R O'Brien was code 99213 (office e&m - established), 54 times for 33 patients. In total Andrew R O'Brien billed 208 services in 16 codes, and Medicare paid $14K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 54 | 33 | $62.06 | $3,351 |
| 99232 Hospital E&M - Subsequent | Facility | 36 | 24 | $57.81 | $2,081 |
| 99213 Office E&M - Established | Facility | 20 | 17 | $46.08 | $922 |
| 99203 Office E&M - New | Office | 11 | 11 | $81.92 | $901 |
By year: 2022 $18K for 263 services; 2023 $16K for 219 services; 2024 $14K for 208 services.
Medicare prescription drug claims, 2024
In 2024, the drug Andrew R O'Brien prescribed most often to Medicare patients was Eliquis (Apixaban), with 126 prescriptions and refills. In total Andrew R O'Brien wrote 497 Medicare prescriptions that cost $245K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 126 | 152 | 23 | $88K |
| Oxycodone Hcl Generic | 67 | 67 | 20 | $1,857 |
| Xarelto Rivaroxaban | 30 | 48 | Under 11 | $26K |
| Nucynta Tapentadol Hcl | 30 | 30 | Under 11 | $25K |
| Enoxaparin Sodium Generic | 28 | 28 | Under 11 | $9,788 |
| Methadone Hcl Generic | 23 | 23 | Under 11 | $532 |
| Morphine Sulfate Er Morphine Sulfate | 23 | 23 | Under 11 | $569 |
| Fondaparinux Sodium Generic | 23 | 23 | Under 11 | $36K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 21 | 21 | Under 11 | $550 |
| Hydroxyurea Generic | 16 | 18 | Under 11 | $415 |
Brand drugs: - claims; generic drugs: 252 claims; opioid claims: 187.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrew R O'Brien $1,276 ($1,276 in general payments such as food, travel and fees) from 3 companies. The largest payer was Terumo BCT, Inc. with $1,125.
| Company | Payments | Amount |
|---|---|---|
| Terumo BCT, Inc. | 1 | $1,125 |
| Novo Nordisk Inc NVO | 1 | $125 |
| Emmaus Medical, Inc. | 1 | $26.09 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.